Zhou Zhen, Zhao Yi, Gu Lingping, Niu Xiaoming, Lu Shun
Department of Lung Tumor Clinical Center, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, P.R. China.
Department of Lung Tumor Clinical Center, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, P.R. China.
Mol Med Rep. 2023 Nov;28(5). doi: 10.3892/mmr.2023.13109. Epub 2023 Oct 6.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that data from the cell adhesion experiment shown in Fig. 11 were strikingly similar to data appearing in different form in Fig. 6B in another article written by different authors at different research institutes [Huang Z, Li J, Du S, Tang Y, Huang L, Xiao L and Tong P: FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome. Oncotarget 7: 39872‑39884, 2016]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 2153‑2160, 2018; DOI: 10.3892/mmr.2017.8173].
在本文发表后,一位关注此事的读者提醒编辑注意,图11所示的细胞黏附实验数据与不同研究机构的不同作者所撰写的另一篇文章中的图6B以不同形式呈现的数据惊人地相似[Huang Z, Li J, Du S, Tang Y, Huang L, Xiao L和Tong P: FKBP14过表达促进骨肉瘤致癌作用并提示生存预后不良。Oncotarget 7: 39872 - 39884, 2016]。由于上述文章中存在争议的数据在提交给本期刊之前就已经发表,编辑决定将本文从该期刊撤回。已要求作者对这些问题作出解释,但编辑部未收到回复。编辑就由此造成的不便向读者表示歉意。[Molecular Medicine Reports 17: 2153 - 2160, 2018; DOI: 10.3892/mmr.2017.8173]